BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 32828126)

  • 41. Bioinformatic Identification of Hub Genes and Analysis of Prognostic Values in Colorectal Cancer.
    Lei X; Jing J; Zhang M; Guan B; Dong Z; Wang C
    Nutr Cancer; 2021; 73(11-12):2568-2578. PubMed ID: 33153324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Bioinformatic Profile of Gene Expression of Colorectal Carcinoma Derived Organoids.
    A P; Xu X; Wang C; Ye L; Yang J
    Biomed Res Int; 2018; 2018():2594076. PubMed ID: 30363662
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
    J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of Prognostic RBPs in Osteosarcoma.
    Li B; Fang L; Wang B; Yang Z; Zhao T
    Technol Cancer Res Treat; 2021; 20():15330338211004918. PubMed ID: 33754909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integration of gene expression data identifies key genes and pathways in colorectal cancer.
    Hozhabri H; Lashkari A; Razavi SM; Mohammadian A
    Med Oncol; 2021 Jan; 38(1):7. PubMed ID: 33411100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioinformatics Analysis of Prognosis-Related Genes and Expression of CXCL8 in Colorectal Cancer.
    Yao Z; Pan X; Chen W; Pei Y; Chen C; Huang Y; Liu S; Liu Y
    Biomed Res Int; 2022; 2022():3149887. PubMed ID: 35845924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The underlying molecular mechanisms and prognostic factors of RNA binding protein in colorectal cancer: a study based on multiple online databases.
    He Q; Li Z; Lei X; Zou Q; Yu H; Ding Y; Xu G; Zhu W
    Cancer Cell Int; 2021 Jun; 21(1):325. PubMed ID: 34193169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Establishment and validation of an RNA binding protein-associated prognostic model for ovarian cancer.
    He C; Huang F; Zhang K; Wei J; Hu K; Liang M
    J Ovarian Res; 2021 Feb; 14(1):27. PubMed ID: 33550985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Construction of an RNA-Binding Protein-Related Prognostic Model for Pancreatic Adenocarcinoma Based on TCGA and GTEx Databases.
    Wen X; Shao Z; Chen S; Wang W; Wang Y; Jiang J; Ma Q; Zhang L
    Front Genet; 2020; 11():610350. PubMed ID: 33584809
    [No Abstract]   [Full Text] [Related]  

  • 50. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
    Gao X; Yang J
    DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
    Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
    World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.
    Makondi PT; Lee CH; Huang CY; Chu CM; Chang YJ; Wei PL
    PLoS One; 2018; 13(1):e0189582. PubMed ID: 29342159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Construction of an miRNA‑gene regulatory network in colorectal cancer through integrated analysis of mRNA and miRNA microarrays.
    Hu J; Yue X; Liu J; Kong D
    Mol Med Rep; 2018 Dec; 18(6):5109-5116. PubMed ID: 30272280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Prognostic Model Based on Six Metabolism-Related Genes in Colorectal Cancer.
    Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
    Biomed Res Int; 2020; 2020():5974350. PubMed ID: 32953885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
    Yu Y; Tian X
    Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 60. Identification of genes involved in the four stages of colorectal cancer: Gene expression profiling.
    Shi G; Wang Y; Zhang C; Zhao Z; Sun X; Zhang S; Fan J; Zhou C; Zhang J; Zhang H; Liu J
    Mol Cell Probes; 2018 Feb; 37():39-47. PubMed ID: 29179987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.